In the present research work, an attempt was made to improve the solubility and dissolution rate of a poorly soluble drug, Gl iclazide by solid dispersion method using soluplus and kollidon VA64 as a carrier and PEG 4000, sorbitol, cremophor EL as a plasticizer. Evaluation of solid dispersion i.e. in vitro- dissolution, differential scanning calorimetry (DSC), Fourier transform infrared (FTIR), X-ray diffraction (XRD) was performed. The solid dispersion of KollidonVA64 and PEG 4000(1:1) showed the best cumulative drug release (72.16±2.01). The solid dispersions were then formulated as tablets and were subjected to various preformulation and post formulations studies. The evaluation of tablet batches i.e. hardness, friability, drug content, ...
Background: Oral bioavailability of gliclazide, a hypoglycemic drug, is hindered by its low aqueous ...
In order to enhance in vitro dissolution and content uniformity of poorly soluble drug glimepiride b...
Gliclazide is a second generation sulphonylurea used in the treatment of type 2 diabetes characteriz...
In the present research work, an attempt was made to improve the solubility and dissolution rate of ...
The present study utilizes approach of solid dispersions (SDs) to improve dissolution rate of Glicla...
The present study utilizes approach of solid dispersions (SDs) to improve dissolution rate of Glicla...
The present study utilizes approach of solid dispersions (SDs) to improve dissolution rate of Glicla...
This article investigates enhancement of the dissolution profile of gliclazide, an antidiabetic drug...
© 2017 Bentham Science Publishers. Background: Low aqueous solubility is a major problem faced with ...
Purpose: The aim of the present study was to characterise gliclazide solid dispersions (SDs) prepar...
Purpose: The aim of the present study was to characterise gliclazide solid dispersions (SDs) prepar...
Objective: The aim of this study was to improve the dissolution rate of gliclazide by developing a s...
Gliclazide is practically insoluble in water and its bioavailability is limited by dissolution rate....
ABSTRACT: The present study was aimed to increase the solubility of the poorly water soluble drug (G...
Glibenclamide is practically insoluble in water and its GI absorption is limited by its dissolution ...
Background: Oral bioavailability of gliclazide, a hypoglycemic drug, is hindered by its low aqueous ...
In order to enhance in vitro dissolution and content uniformity of poorly soluble drug glimepiride b...
Gliclazide is a second generation sulphonylurea used in the treatment of type 2 diabetes characteriz...
In the present research work, an attempt was made to improve the solubility and dissolution rate of ...
The present study utilizes approach of solid dispersions (SDs) to improve dissolution rate of Glicla...
The present study utilizes approach of solid dispersions (SDs) to improve dissolution rate of Glicla...
The present study utilizes approach of solid dispersions (SDs) to improve dissolution rate of Glicla...
This article investigates enhancement of the dissolution profile of gliclazide, an antidiabetic drug...
© 2017 Bentham Science Publishers. Background: Low aqueous solubility is a major problem faced with ...
Purpose: The aim of the present study was to characterise gliclazide solid dispersions (SDs) prepar...
Purpose: The aim of the present study was to characterise gliclazide solid dispersions (SDs) prepar...
Objective: The aim of this study was to improve the dissolution rate of gliclazide by developing a s...
Gliclazide is practically insoluble in water and its bioavailability is limited by dissolution rate....
ABSTRACT: The present study was aimed to increase the solubility of the poorly water soluble drug (G...
Glibenclamide is practically insoluble in water and its GI absorption is limited by its dissolution ...
Background: Oral bioavailability of gliclazide, a hypoglycemic drug, is hindered by its low aqueous ...
In order to enhance in vitro dissolution and content uniformity of poorly soluble drug glimepiride b...
Gliclazide is a second generation sulphonylurea used in the treatment of type 2 diabetes characteriz...